Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Retraction Free access | 10.1172/JCI121856

Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling

Alexandra Zanin-Zhorov, Liora Cahalon, Guy Tal, Raanan Margalit, Ofer Lider, and Irun R. Cohen

Find articles by Zanin-Zhorov, A. in: PubMed | Google Scholar

Find articles by Cahalon, L. in: PubMed | Google Scholar

Find articles by Tal, G. in: PubMed | Google Scholar

Find articles by Margalit, R. in: PubMed | Google Scholar

Find articles by Lider, O. in: PubMed | Google Scholar

Find articles by Cohen, I. in: PubMed | Google Scholar

Published May 7, 2018 - More info

Published in Volume 128, Issue 6 on June 1, 2018
J Clin Invest. 2018;128(6):2651–2651. https://doi.org/10.1172/JCI121856.
Copyright © 2018, American Society for Clinical Investigation
Published May 7, 2018 - Version history
View PDF

Related article:

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling
Alexandra Zanin-Zhorov, … , Ofer Lider, Irun R. Cohen
Alexandra Zanin-Zhorov, … , Ofer Lider, Irun R. Cohen
Research Article Immunology

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

  • Text
  • PDF
Abstract

CD4+CD25+ Tregs regulate immunity, but little is known about their own regulation. We now report that the human 60-kDa heat shock protein (HSP60) acts as a costimulator of human Tregs, both CD4+CD25int and CD4+CD25hi. Treatment of Tregs with HSP60, or its peptide p277, before anti-CD3 activation significantly enhanced the ability of relatively low concentrations of the Tregs to downregulate CD4+CD25– or CD8+ target T cells, detected as inhibition of target T cell proliferation and IFN-γ and TNF-α secretion. The enhancing effects of HSP60 costimulation on Tregs involved innate signaling via TLR2, led to activation of PKC, PI3K, and p38, and were further enhanced by inhibition of ERK. HSP60-treated Tregs suppressed target T cells both by cell-to-cell contact and by secretion of TGF-β and IL-10. In addition, the expression of ERK, NF-κB, and T-bet by downregulated target T cells was inhibited. Thus, HSP60, a self-molecule, can downregulate adaptive immune responses by upregulating Tregs innately through TLR2 signaling.

Authors

Alexandra Zanin-Zhorov, Liora Cahalon, Guy Tal, Raanan Margalit, Ofer Lider, Irun R. Cohen

×

Original citation: J Clin Invest. 2006;116(7):2022–2032. https://doi.org/10.1172/JCI28423

Citation for this retraction: J Clin Invest. 2018;128(6):2651. https://doi.org/10.1172/JCI121856

At the request of the corresponding author, the JCI is retracting this article. The authors were recently made aware of duplicated bands in Figure 8E as well as portions of Figure 8D that were reused in another publication (Zanin-Zhorov A., et al. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol. 2007;179(1):41–44.). After an extensive internal review, it became apparent that these duplications were introduced during figure assembly. The authors have stated that, after being made aware of the duplicated bands, they repeated the gel experiments and the results supported the conclusions of the original study. Moreover, other studies have subsequently confirmed and extended the primary conclusions of the manuscript. Nevertheless, the authors wish to retract this article because of the importance of accuracy and transparency in the published scientific literature.

The authors apologize for these errors.

Footnotes

See the related article at Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling.

Version history
  • Version 1 (May 7, 2018): Electronic publication
  • Version 2 (June 1, 2018): Print issue publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts